Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 8.97 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 8.5 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 9.66 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 8.49 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 7.86 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 11.3 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 9.86 | pmol/sample |
| LMFA01030089 | cis-erucic acid | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 12.5 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 0.0 | BCD100427B001 | 6.39 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 0.5 | BCD100427B003 | 7.3 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 1.0 | BCD100427B007 | 5.8 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 2.0 | BCD100427B011 | 6.39 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 4.0 | BCD100427B015 | 4.89 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 8.0 | BCD100427B019 | 8.83 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 12.0 | BCD100427B023 | 9.56 | pmol/sample |
| LMFA01030089 | cis-erucic acid | C | 24.0 | BCD100427B027 | 7.44 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 8.02 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 8.7 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 10.2 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 12.7 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 15.9 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 14.1 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 14.5 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 0.5 | BCD100427B004 | 5.32 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 1.0 | BCD100427B008 | 7.25 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 2.0 | BCD100427B012 | 7.46 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 4.0 | BCD100427B016 | 6.92 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 8.0 | BCD100427B020 | 9.31 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 12.0 | BCD100427B024 | 8.47 | pmol/sample |
| LMFA01030089 | cis-erucic acid | 25OH-Chol | 24.0 | BCD100427B028 | 9.44 | pmol/sample |